Please Wait
Applying Filters...
menu
    • menu
    Mix Gif-PSE
    News
    Archimica Explore Sucrose Octasulfate Potassium Salt (KSOS)

    26 Jan 2026

    // PRESS RELEASE

    PI Health announces the acquisition of Archimica From Livia Group

    15 Oct 2025

    // PRESS RELEASE

    Axyntis, independent, multi-site leader in the strategic sector

    27 Mar 2017

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Archimica VB RM

    Contact Supplier

    Website

    Arvo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued
    Menu

    Archimica

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Archimica S.p.A

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-06-15

    Archimica

    City : Lodi

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-06-15

    CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-09-13

    Archimica

    City : Lodi

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-09-13

    CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-07-21

    Archimica

    City : Lodi

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-07-21

    CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-04-28

    Archimica

    City : Lodi

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-04-28

    CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-09-25

    Archimica

    City : Lodi

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-09-25

    CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2011-09-08

    Archimica

    City : Lodi

    State :

    Country/Area : Italy

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2011-09-08

    CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Archimica and get a quotation

    Archimica is a supplier offers 14 products (APIs, Excipients or Intermediates).

    Find Cytarabine bulk with DMF, CEP offered by Archimica

    Find Hydroxyurea bulk with DMF, CEP offered by Archimica

    Find Bromfenac bulk with DMF offered by Archimica

    Find Capecitabine bulk with DMF offered by Archimica

    Find Cytarabine bulk with CEP offered by Archimica

    Find Disopyramide bulk with DMF offered by Archimica

    Find Hydralazine Hydrochloride bulk with DMF offered by Archimica

    Find Lithium Carbonate bulk with DMF offered by Archimica

    Find Mianserin Hydrochloride bulk with CEP offered by Archimica

    Find Oxcarbazepine bulk with DMF offered by Archimica

    Find Pirenzepine bulk with DMF offered by Archimica

    Find Sucralfate bulk with DMF offered by Archimica

    Find Sulfapyridine bulk with DMF offered by Archimica

    Find Choline Alfoscerate bulk offered by Archimica

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.